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Summary objectives To assess if the clinical outcome of patients treated after performing a Rapid Diagnostic
Test for malaria (RDT) is at least equivalent to that of controls (treated presumptively without test) and
to determine the impact of the introduction of a malaria RDT on clinical decisions.
methods Randomized, multi-centre, open clinical trial in two arms in 2006 at the end of the dry and of
the rainy season in 10 peripheral health centres in Burkina Faso: one arm with use of RDT before
treatment decision, one arm managed clinically. Primary endpoint: persistence of fever at day 4. Sec-
ondary endpoints: frequency of malaria treatment and of antibiotic treatment.
results A total of 852 febrile patients were recruited in the dry season and 1317 febrile patients in the
rainy season, and randomized either to be submitted to RDT (P_RTD) or to be managed presumptively
(P_CLIN). In both seasons, no signiﬁcant difference was found between the two randomized groups in
the frequency of antimalarial treatment, nor of antibiotic prescription. In the dry season, 80.8% and
79.8% of patients with a negative RDT were nevertheless diagnosed and treated for malaria, and so
were 85.0% and 82.6% negative patients in the rainy season. In the rainy season only, both diagnosis
and treatment of other conditions were signiﬁcantly less frequent in RDT positive vs. negative patients
(48.3% vs. 61.4% and 46.2% vs. 59.9%, P = 0.00 and 0.00, respectively).
conclusion Our study was inconclusive on RDT safety (clinical outcome in the two randomized
groups), because of an exceedingly and unexpectedly low compliance with the negative test result.
Further research is needed on best strategies to promote adherence and on the safety of a test based
strategy compared with the current, presumptive treatment strategy.
keywords malaria management, malaria diagnosis, fever management, rapid diagnostic test, RDT
safety, clinical decision
Introduction
In recent years, following WHO recommendations, most
African countries have adopted treatment protocols for
malaria based on artemisinin combination treatments
(ACT) (Ogbonna & Uneke 2008). The new protocols have
proven to be very effective, but they are also much more
expensive than previous regimens. The presumptive treat-
ment of all fevers for malaria, previously a current practice,
has therefore being questioned on economical grounds
(Pfeiffer et al. 2008). Moreover, presumptive treatment is
considered potentially dangerous as it might contribute to
selecting for resistant Plasmodium falciparum strains. New
guidelines for malaria management recommend a manda-
tory laboratory test before malaria treatment (WHO
2006). In many African areas without laboratory facilities,
the only possibility is the use of a rapid diagnostic test
(RDT).
Paracheck
  (Orchid Biomedical Systems, Goa, India) is
the most widely used RDT. It is based on the detection of
the P. falciparum speciﬁc HRP-2 protein and diagnoses
malaria infection rapidly and with reasonable accuracy
according to most studies, with 90.1–100% sensitivity and
52–99.5% speciﬁcity (Guthmann et al. 2002; Singh &
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In Burkina Faso the adoption of the new ACT based
strategy is very recent, and in 2006 had yet to be
implemented. In a context of a highly variable, seasonal
transmission, the safety and utility of the introduction of a
RDT for malaria was discussed. We decided therefore to
study the safety, utility and cost-effectiveness of a RDT
based strategy vs. the current, presumptive clinical man-
agement in a region where malaria incidence is highest, and
where no laboratory facility is available at periphery. We
also wanted to assess how the prescribing behaviour of
health personnel (nurses) was affected by the availability of
the new test, and in particular, the adherence to a negative
test result. Safety and adherence are the object of the
present paper. The safety did not concern RDT testing in
itself, but rather the subsequent prescribing; theoretically,
harm could be caused both by a false negative and a false
positive result (Bisofﬁ & Van den Ende 2008): False
negatives would not be treated for malaria; false positives
would risk to be left without treatment for the true cause of
their fever. We aimed to assess if the new strategy would be
at least equivalent to the previous (presumptive) one in
terms of short term clinical outcome. The issue of
adherence to malaria diagnosis has recently been
investigated (Reyburn et al. 2004, 2007; Hamer et al.
2007), but most of these studies were not yet published at
the time of our ﬁeld study (2006). The cost effectiveness of
RDT based strategies has been questioned due to
lower-than-expected compliance of health workers with
the (negative) test result (Bisofﬁ & Van den Ende 2008;
Lubell et al. 2008).
We hypothesized that (i) the short-term health outcome
should not be worse in the group submitted to RDT; (ii)
less frequent malaria treatment, and more frequent treat-
ment for other causes of fever, mainly antibiotics, should
be observed in febrile patients with a negative RTD result;
(iii) the opposite should be observed in febrile patients with
a positive RTD result. Thus our objectives were: to assess if
the short-term outcome (day 4) of patients treated after
performing a RDT is at least equivalent (not inferior) to
that of controls (without RDT) in terms of clearance of
fever and of other major symptoms and signs; and to assess
the impact of the introduction of a malaria rapid diagnostic
tests (RDT) on clinical decisions by health ofﬁcers.
Patients and methods
Type of study
This was a randomized, multi-centre, open clinical trial
(RCT) in two arms: one arm with use of RDT before
treatment decision (cases or P_RTD), the other managed
clinically according to national guidelines (controls or
P_CLIN). The primary endpoint was the persistence of
fever at day 4. Secondary endpoints were persistence of
other main clinical ﬁndings at day 4, frequency of malaria
treatment in both randomized groups and according to
RDT result, frequency of antibiotic treatment in both
randomized groups and according to RDT result.
Patients
The study took place in 10 peripheral health centres of the
provinces of Bobo Dioulasso and Banfora, south-west
Burkina Faso, an area with stable malaria and with a
seasonal transmission pattern. The health centres were
selected according to convenience criteria such as: number
of malaria cases reported in previous years; geographical
(and urban⁄rural) representativeness; sufﬁcient number of
health professionals able to carry out the study. Half of the
centres were supported by the health project An Ka
Heresso, ﬁnanced by the Italian Foundation UNIDEA and
carried out by an Italian NGO, while the others were
public health facilities with no special external support.
Inclusion criteria were: age ‡6 months and presenting at
the health centre with an axillary temperature ‡37.5  C.
Exclusion criteria were severe clinical condition requiring
urgent action. All patients attending the health centres
were initially assessed by ordinary dispensary staff (in the
study area all were nurses) who decided on eligibility for
inclusion. Eligible patients were given (by research assis-
tants) a detailed explanation of the study and asked for
informed consent. Patients included in the study were
assigned to either arm based on the randomization list (see
below). Research assistants directly assisted at the follow-
ing consultation carried out by the nurse, ﬁlled in a
standardized questionnaire reporting main clinical ﬁnd-
ings, the working and ﬁnal diagnosis and all treatments
administered, and performed the RDT (for P_RDT) and a
thick and thin ﬁlm (for all), to be stored for subsequent
reading.
Sample size
The sample size was determined for the primary
endpoint, that is, fever persistence at follow-up (day 4).
This was used as a surrogate for severe outcomes that
were expected to be very rare and would have needed a
sample size not attainable by this study. For an expected
frequency of fever persistence at day 4 in subjects
managed clinically (P_CLIN) of 40% and a maximal
expected difference of 10% (for a power of the study of
80% and an alpha error of 5%), a sample size of 814 in
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least 500 subjects per arm in both seasons, in order to
account for loss to follow up.
Randomization
Febrile patients included in the trial were assigned to either
arm based on a computer-generated random list. In each
study period of 1 month at the end of the dry and rainy
season, all patients included were randomized to be
submitted to RDT (Paracheck
  test) (cases or P_RTD), or
to be managed clinically (controls or P_CLIN).
Clinical management and follow-up
Clinical ﬁndings were recorded for all patients. In case of
death the circumstances were investigated in depth and
additional data were recorded in a separate notebook. The
dispensary staff (nurses) remained responsible for the ﬁnal
diagnosis and treatment. Research assistants communi-
cated (and showed) the test result of P_RDT to the nurses,
but they were not authorized to question their decisions. A
follow-up was carried out for all patients at day 4, when
patients where examined again: those who failed to attend
the clinic at day 4 were visited at home the same day or at
latest the following day by research assistants.
Training
Research assistants (most were recently graduated, still
unemployed junior nurses) were specially recruited for the
study. They were intensively trained for 3 days on the
study protocol and on the correct execution and reading of
the RDT. The dispensary nurses were also trained on RDT
reading and RDT performances as reported by literature.
Key messages were that a negative RDT result virtually
excluded clinical malaria, while a positive result did not
rule out other possible causes of fever. Only Paracheck
 
result should be used for decision of malaria treatment for
cases (P_RDT). Treatment of controls (P_CLIN), and
treatment of any other condition for both cases and
controls, should solely depend on the judgment of the
clinical ofﬁcer, based on the national diagnostic guidelines.
Before the second phase of the ﬁeld study in the rainy
season, a booster training for three more days was given to
both the research assistants and the nurses.
Ethical clearance
The study protocol was approved by the ‘Comite ´ National
d’Ethique’ (National Ethical Committee) of Burkina Faso.
Written informed consent was obtained through the use of
an information sheet with detailed explanation of the
purpose of the study and the procedures involved. Once the
nurse had decided that a patient was eligible for inclusion,
a member of the investigational staff gave the explanation
in local language, in the presence of an independent
witness. In case of agreement, the informed consent form
was signed both by the patient (or one of the parents in
case of minors) and by the witness. Illiterate participants
signed by ﬁngerprint.
Data management and statistical analysis
Data (all categorical) were double entered and analysed
with Epi Info software (EpiInfo, CDC Atlanta, version
3.3.2). The association between variables was expressed by
odds ratio (OR) and its 95% conﬁdence limits. Uncor-
rected chi-square test and the corresponding p values were
used for statistical inference. Fisher exact test was used for
values <5.
Results
As shown in the ﬂow charts (Figures 1 and 2), 2861
patients were assessed for potential inclusion in the study
in the dry season and 3573 in the rainy season. One
thousand nine hundred and ninety-ﬁve and 2237
respectively did not respond to the inclusion criteria for
reasons outlined in the ﬂow charts, but 866 and 1336
were eligible for inclusion, of whom 14 and 19,
respectively, refused. The remaining 852 and 1317
patients were recruited and randomized either to the
RDT (P_RTD) or presumptive management on clinical
grounds only (P_CLIN).
Of 852 febrile patients recruited in the dry season, 404
were submitted to the RDT and 448 treated presumptively.
Of 1317 recruited in the rainy season 654 had RDT and
663 presumptive treatment. Demographic and clinical
characteristics were evenly distributed in the randomized
groups (Table 1).
Clinical outcome
Follow-up at day 4 was possible for 813 of 852 patients in
the dry season (95.4%) and 1282⁄1317 patients (97.3%)
in the rainy season. In the dry season, four deaths (two
infants aged 10 and 15 months, respectively, and two
adults) were recorded in the P_RDT group vs. three deaths
(all infants) in the P_CLIN group (P = 0.71), while in the
rainy season one death was reported in each cohort (one
infant submitted to RDT and one adult not submitted)
(P = 1). Subsequent microscopy showed that in the dry
season no fatality was due to malaria (in only one case was
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120 parasites⁄ll). One of the infants had been treated for
malaria only, after a positive RDT test, which was
subsequently found to be a false positive. The infant who
died in the rainy season had a malaria infection at very high
parasitaemia (about 15%) and was appropriately treated
after a positive RDT; the adult had no malaria parasite and
presumably died of pneumonia.
The rates of persistence of fever (8.2% in both groups in
the dry season, 3.9 vs. 3.7% in the rainy season) and of
other symptoms (20.1 vs. 20.3% in the dry season, 6.4 vs.
8.5% in the rainy season) were also similar in both groups
(Table 2).
Comparing the seasons as a whole, a signiﬁcant worse
outcome was found in the dry season (Table 3): lower rate
of resolution of fever and of other symptoms (8.2% and
20.1% vs. 3.8% and 7.4%, respectively: P = 0.00 and
0.00), and higher death rate (7⁄813 or 0.9% vs.2⁄1282 or
0.16%: P = 0.03).
Clinical decision
In the dry season, the rapid test result was positive in 113
of 404 (28%) patients and indeterminate in 4 (not
considered in the analysis). In the rainy season, the RDT
result was positive in 443 of 650 (68.2%) cases and
indeterminate in four (not considered in the analysis). In
both seasons, no signiﬁcant difference was found between
the two randomized groups in the frequency of ﬁnal
diagnosis of malaria (83.7% vs. 80.8% in dry season,
P = 0.28, and 92.7% vs. 91.9% in rainy season, P = 0.58)
and antimalarial treatment (84.2% vs. 80.1% in dry
season, P = 0.13, and 92.5% vs. 92.0% in rainy season,
P = 0.73) (Table 4).
In the dry season, an alternative diagnosis was made
more often in P_CLIN than in P_RTD (73% vs. 64%,
P = 0.00), but with no signiﬁcant difference in antibiotic
prescription (56.7% vs. 61.4%, P = 0.16). In the rainy
season, both the frequency of other diagnoses and of
Assessed for eligibility 
n = 2861
Not meeting inclusion criteria 
 -Patients < 6 month old    n = 211
-Emergencies    n = 93
Examined 
n = 2557
T° < 37.5 °C 
n = 1691 
Eligible for inclusion 
n = 866
Consent refused 
n = 14 
Enrolled
n = 852
Lost to follow-up 
n = 39 
Follow-up day 4  
n = 813
Figure 1 Trial proﬁle, dry season.
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vs. 51.9%, P = 0.83, and 50.6% vs. 50.3%, P = 0.93,
respectively) (Table 4).
A further analysis was carried out in the P_RDT arm
only, in order to assess how decisions were inﬂuenced by
the RDT result. As expected, in both seasons the frequency
of malaria diagnosis and treatment was signiﬁcantly higher
for positive vs. negative RDT results (Table 5). In the dry
season, 92% and 95.6% of patients with a positive RDT
Table 1 Comparison of randomized groups
RDT Clinical P
Sex
M 517 (49.1%) 538 (48.6%) 0.96
F 527 (49.1%) 559 (50.5%)
Age (years)
(median)
4Q 1=1 ,
Q2 = 19
4Q 1=1 ,
Q2 = 18
0.98
T  (median) 38.3 Q1 = 37.8,
Q2 = 39.1
38.3Q1 = 37.7,
Q2 = 39
0.21
Vomiting 30.5% 29.9% 0.75
Diarrhoea 19.7% 20.7% 0.56
Cough 41.3% 41.2% 0.97
Skin rash 3.3% 2.7% 0.40
CNS alteration 1.3% 1.1% 0.46
ENT symptoms 3.8% 5.3% 0.08
Positive thick ﬁlm 48.6% 46.2% 0.26
Assessed for eligibility 
n = 3573
Not meeting inclusion criteria 
 -Patients < < 6 month old n = 273   
-Emergencies n = 98   
Examined 
n = 3202
T° < 37.5 °C 
n = 1866 
Eligible for inclusion 
n = 1336
Consent refused 
n = 19 
Enrolled
n = 1317
Lost to follow-up 
n = 35
Follow-up day 3  
n = 1282
Figure 2 Trial proﬁle, rainy season.
Table 2 Clinical outcome at follow-up (day 4th) in the two arms
RDT (%) Clinical (%) p
Dry season
Death 4⁄388 (1.0) 3⁄425 (0.7) 0.71
Persistence of fever 32⁄388 (8.2) 35⁄425 (8.2) 0.99
Persistence of other
symptoms
78⁄388 (20.1) 86⁄425 (20.2) 0.96
Rainy season
Death 1⁄636 (0.15) 1⁄646 (0.15) 1
Persistence of fever 25⁄636 (3.9) 24⁄646 (3.7) 0.83
Persistence of other
symptoms
41⁄636 (6.4) 55⁄646 (8.5) 0.16
Tropical Medicine and International Health volume 14 no 4 pp 1–8 april 2009
Z. Bisofﬁ et al. Rapid malaria diagnostic tests vs. clinical management
ª 2009 Blackwell Publishing Ltd 5were diagnosed and treated for malaria, vs. 80.8% and
79.8% with a negative RDT (P = 0.00 and 0.00). In the
rainy season, 96.2% and 98.2% of positive patients were
diagnosed and treated for malaria, vs. 85.0% and 82.6%
of negative patients (P = 0.00 and 0.00).
In the dry season the two arms did not differ signiﬁcantly
in the frequency of other diagnoses or antibiotic prescrip-
tion (66.4% vs. 62.5% and 61.0% vs. 54.7%, P = 0.45
and 0.25, respectively) (Table 5). This was not the case in
the rainy season, when the diagnosis and treatment of
other conditions were less frequent in RDT positive
patients (48.3% vs. 61.4% and 46.2% vs. 59.9%, P = 0.00
and 0.00, respectively) (Table 5). The additional training
had no apparent effect on the diagnosis and treatment of
malaria and of other conditions for RTD negative patients
(Table 6).
Discussion
Despite a growing mass of literature on RDT for malaria,
we were surprisingly unable to ﬁnd any single paper on the
safety of a RDT based strategy, compared with presump-
tive malaria management, and very few articles on adher-
ence to RDT results (Hamer et al. 2007; Reyburn et al.
2007; Lubell et al. 2008). Test based strategies might fail
their purpose to save unnecessary costs, and be even
dangerous, if clear evidence on both aspects is not provided
(Bisofﬁ & Van den Ende 2008; Lubell et al. 2008).
No signiﬁcant difference was found in the clinical
outcome between the two randomized groups (Table 2).
Because of the poor adherence to the test result, we were
not able to show if the RDT based strategy can be
considered safe. Other authors found that malaria infec-
tions missed by microscopy and therefore untreated are not
associated with mortality risk (Njama-Meya et al. 2007).
Similar evidence for RDT is, however, still lacking.
Another potential harm affects RDT false positive
patients. In endemic areas the presence of malaria parasites
in blood may not reﬂect a clinical malaria episode
(Schellenberg et al. 1994). Thus some febrile, RDT positive
patients may be simple carriers of malaria parasites, with
another (potentially severe) disease. The harm from a
missed treatment, under the inﬂuence of a positive malaria
test, might not be negligible. In one case in the dry season,
a child with a false positive RDT result was treated for
malaria only and subsequently died (presumably of pneu-
monia). The difference in mortality and clinical outcome
between the two seasons (Table 3), as was recently found
in Burkina Faso by other authors, raises concern (Kynast-
Wolf et al. 2006). The difference might be due to a
Table 3 Clinical outcome at follow-up (day 4th) in the two sea-
sons
Dry season (%) Rainy season (%) P
Death 7⁄813 (0.9) 2⁄1282 (0.16) 0.03
Persistence of fever 67⁄813 (8.2) 49⁄1282 (3.8) 0.00
Persistence of other
symptoms
164⁄813 (20.1) 96⁄1282 (7.4) 0.00
Table 4 Diagnosis and treatment of malaria and other conditions
in the two arms
RDT (%) Clinical (%) P
Dry season
Diagnosis of malaria 338⁄404 (83.7) 362⁄448 (80.8) 0.28
Antimalarial treatment 340⁄404 (84.2) 359⁄448 (80.1) 0.13
Other diagnosis 257⁄404 (63.7) 328⁄448 (73.2) 0.00
Antibiotic treatment 229⁄404 (56.7) 275⁄448 (61.4) 0.16
Rainy season
Diagnosis of malaria 606⁄654 (92.7) 609⁄663 (91.9) 0.58
Antimalarial treatment 605⁄654 (92.5) 610⁄663 (92.0) 0.73
Other diagnosis 343⁄654 (52.4) 344⁄663 (51.9) 0.83
Antibiotic treatment 331⁄654 (50.6) 334⁄663 (50.3) 0.93
Table 5 Malaria diagnosis and treatment according to RDT result
Positive
RDT (%)
Negative
RDT (%) P
Dry season
Diagnosis of malaria 104⁄113 (92.0) 232⁄287 (80.8) 0.00
Antimalarial treatment 108⁄113 (95.6) 229⁄287 (79.8) 0.00
Other diagnosis 75⁄113 (66.4) 179⁄287 (62.5) 0.45
Antibiotic treatment 69⁄113 (61.0) 157⁄287 (54.7) 0.25
Rainy season
Diagnosis of malaria 426⁄443 (96.2) 176⁄207 (85.0) 0.00
Antimalarial treatment 435⁄443 (98.2) 171⁄207 (82.6) 0.00
Other diagnosis 214⁄443 (48.3) 127⁄207 (61.4) 0.00
Antibiotic treatment 205⁄443 (46.2) 124⁄207 (59.9) 0.00
Table 6 Effect of training: comparison
between both seasons regarding diagnosis
and treatment of malaria and other condi-
tions
Diagnosis and treatment Dry season (%) Rainy season (%) P
RDT negatives diagnosed as malaria 232⁄287 (80.8) 176⁄207 (85.0) 0.28
RDT negatives treated for malaria 229⁄287 (79.8) 171⁄207 (82.6) 0.50
Alternative diagnoses in RDT negatives 179⁄287 (62.5) 127⁄207 (61.4) 0.89
Antibiotic treatment in RDT negatives 157⁄287 (54.7) 124⁄207 (59.9) 0.29
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and⁄or to the fact that a patient was less likely to receive
the appropriate treatment for her⁄his condition in the dry
season when malaria is much less frequent.
No signiﬁcant difference was found in either season
between the two randomized groups for clinical decisions
concerning malaria diagnosis and treatment. Other poten-
tial causes of fever were more frequently diagnosed in the
dry season, though the frequency of antibiotic treatment
was similar in the two arms (Table 4). In both seasons a
positive RDT result was signiﬁcantly correlated with the
decision to treat for malaria (Table 5), but negative
patients were also diagnosed as malaria cases in 80% (dry
season) to 85% (rainy season) of cases. The expected,
higher frequency of alternative diagnoses and treatments
after a negative RDT result was only observed in the rainy
season (after a second intensive 3-day training session)
(Table 5). In general, more than half patients were treated
with antibiotics, in both arms and in both seasons
(Table 4), and so were about half patients with a positive
RDT, despite being almost all diagnosed as malaria cases
(Table 5). The so called ‘double diagnosis’ (and treatment)
is questioned by Public Health ofﬁcers as a waste of
resources. In individual care, however, nurses often prefer
to treat a potentially harmful cause of fever if they cannot
rule it out.
Other authors have very recently addressed the adher-
ence issue in African, Anglophone countries, (Hamer et al.
2007; Reyburn et al. 2007; Lubell et al. 2008) while we are
not aware of any published study from Francophone Africa
as yet. While the above referred studies have generally
found a poor compliance with the negative test result, none
has shown such a low adherence as in ours. Undoubtedly
local concepts of illness inﬂuence malaria management
(Beiersmann et al. 2007; Some & Zerbo 2007). Moreover,
nurses were not compelled to refrain from malaria treat-
ment in case of a negative result. This could be regarded as
a major ﬂaw in the study design. Also, ACT were not yet
available in most health facilities: cheaper regimens (gen-
erally including amodiaquine), were used in most cases.
Other authors have found in Kenya that clinical ofﬁcers
tend to reserve ACT for positive cases, and to treat negative
patients with cheaper regimens (Zurovac et al. 2008).
During the second training session in the rainy season, it
was particularly stressed that a negative test virtually
excludes malaria. The result was frustrating. Even more
negative patients were treated for malaria than in dry
season (Table 6), probably reﬂecting the conviction that in
the rainy season every febrile patient has malaria. Nurses
intuitively feel that the pre-test probability of malaria is so
high, that the disease remains likely even after a negative
test.
This study has a major limitation. As we did not expect
such poor adherence, the study failed to fulﬁl its ﬁrst
objective, that was, to assess a possible difference in
clinical outcome between the two arms. One can argue that
the study design was ﬂawed, because in order to fulﬁl the
main objective, adherence should have been enforced and
strictly supervised. A posteriori, this is obviously true, but
we planned to study the safety issue under near-real
conditions, rather than in a quasi-experimental context
that might not reﬂect everyday practice.
Some operational constraints must also be acknowl-
edged. Not all clinical ofﬁcers of the 10 health centres
participating in the study were trained, due to logistic
problems: while it was agreed that patients should be
attended by trained nurses during the study period, this did
not always prove possible. In some cases, the study
supervisors found that the diagnosis and treatment decision
were made before knowing the RDT result. Clearly, if this
happened in the context of an intensively supervised study,
we may expect it to occur even more in everyday practice.
Finally, as the frequency of fever persistence at follow-up
was lower than expected in both arms, the sample size
would have been inadequate to the primary endpoint in
any case.
Safety of a RDT-based strategy (especially for children
below 5 years) remains a fundamental issue that should be
addressed by future research. If safety is clearly demon-
strated, policies to promote adherence will have a better
evidence base (Bisofﬁ & Van den Ende 2008) Evidence in
this respect should probably be pooled from different study
settings in different countries. More research is also needed
on adherence. Policy makers should seriously consider the
issue of (non) adherence to diagnostic tests. Operational
research should concentrate on effective strategies to
promote compliance.
Conclusion
This study proves once more that the widespread intro-
duction of RDT in malaria endemic countries is far from
reaching the expected results. RDT for malaria can only be
useful and cost effective if an acceptable compliance with
the (negative) test result were achieved. Training and
supervision should focus on clear, unambiguous guidelines
to this purpose. The safety of RDT-based malaria man-
agement, especially for children, has not yet been proven,
and requires further investigation.
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